SI1885350T1 - Formulacije in postopki za zdravljenje amiloidoze - Google Patents

Formulacije in postopki za zdravljenje amiloidoze

Info

Publication number
SI1885350T1
SI1885350T1 SI200631906T SI200631906T SI1885350T1 SI 1885350 T1 SI1885350 T1 SI 1885350T1 SI 200631906 T SI200631906 T SI 200631906T SI 200631906 T SI200631906 T SI 200631906T SI 1885350 T1 SI1885350 T1 SI 1885350T1
Authority
SI
Slovenia
Prior art keywords
formulations
methods
treating amyloidosis
amyloidosis
treating
Prior art date
Application number
SI200631906T
Other languages
English (en)
Inventor
Denis Garceau
Wendy Hauck
Richard Briand
Original Assignee
Kiacta Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kiacta Sarl filed Critical Kiacta Sarl
Publication of SI1885350T1 publication Critical patent/SI1885350T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SI200631906T 2005-04-15 2006-04-17 Formulacije in postopki za zdravljenje amiloidoze SI1885350T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67186605P 2005-04-15 2005-04-15
PCT/IB2006/002540 WO2007004072A2 (en) 2005-04-15 2006-04-17 Formulations and methods for treating amyloidosis
EP06795492.5A EP1885350B9 (en) 2005-04-15 2006-04-17 Formulations and methods for treating amyloidosis

Publications (1)

Publication Number Publication Date
SI1885350T1 true SI1885350T1 (sl) 2015-06-30

Family

ID=37499595

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631906T SI1885350T1 (sl) 2005-04-15 2006-04-17 Formulacije in postopki za zdravljenje amiloidoze

Country Status (25)

Country Link
US (3) US8178580B2 (sl)
EP (2) EP2944308A1 (sl)
JP (2) JP2008535906A (sl)
KR (2) KR20130133915A (sl)
CN (2) CN104873483A (sl)
AU (1) AU2006264498B2 (sl)
BR (1) BRPI0610592A2 (sl)
CA (1) CA2582556C (sl)
DK (1) DK1885350T3 (sl)
EA (1) EA018898B1 (sl)
ES (1) ES2534553T3 (sl)
HK (2) HK1116686A1 (sl)
HR (1) HRP20150320T1 (sl)
HU (1) HUE026044T2 (sl)
IL (2) IL186544A (sl)
ME (1) ME02149B (sl)
MX (1) MX2007012525A (sl)
NO (1) NO20075815L (sl)
PL (1) PL1885350T3 (sl)
PT (1) PT1885350E (sl)
RS (1) RS54050B1 (sl)
SI (1) SI1885350T1 (sl)
TW (1) TW200716088A (sl)
WO (1) WO2007004072A2 (sl)
ZA (1) ZA200709825B (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001003680A2 (en) * 1999-07-09 2001-01-18 Isis Innovation Limited Compounds for inhibiting diseases and preparing cells for transplantation
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
US20070049638A1 (en) * 2005-07-21 2007-03-01 Neurochem (International) Limited Polymorphic forms of 3-amino-1-propanesulfonic acid
ES2352801T3 (es) 2005-12-22 2011-02-23 Kiacta Sàrl Tratamiento de nefropatía diabética.
PL3851447T3 (pl) 2006-10-12 2024-03-04 Bellus Health Inc. Sposoby, związki, kompozycje i nośniki dostarczające kwas 3-amino-1-propanosulfonowy
CN101730529A (zh) * 2006-12-22 2010-06-09 贝鲁斯健康(国际)有限公司 用于治疗代谢疾病和糖尿病的方法、化合物和组合物
CA2768877A1 (en) 2009-08-10 2011-02-17 Bellus Health Inc. Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
CN103180445B (zh) 2010-10-22 2018-02-16 库尔纳公司 通过抑制α‑L‑艾杜糖醛酸酶(IDUA)的天然反义转录物而治疗IDUA相关疾病
BR112016025244A2 (pt) 2014-04-30 2018-05-15 Icahn School Of Medicine At Mount Sinai uso de ácido 1,3-propanodissulfônico ou sais farmaceuticamente aceitáveis dos mesmos para o tratamento de sarcoidose.
WO2016023911A1 (en) * 2014-08-11 2016-02-18 Kiacta Sàrl Use of 1,3-propanedisulfonic acid or salts thereof to prevent the onset of amyloidosis in select populations
CN116143672B (zh) * 2023-02-28 2024-03-29 卫星化学股份有限公司 水溶性抗氧剂及其制备方法和应用

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2531468A (en) 1949-04-14 1950-11-28 Eastman Kodak Co Polyvinyl sulfonates and process for their preparation
DE1122064B (de) 1960-01-09 1962-01-18 Basf Ag Verfahren zur Einfuehrung von alyphatischen Kohlenwasserstoffresten in organische Verbindungen, die Hydroxylgruppen, tertiaere Aminogruppen, aromatische gebundene Sulfhydrylgruppen und bzw. oder aromatisch gebundene primaere oder sekundaere Aminogruppen enthalten
US3218352A (en) 1962-05-03 1965-11-16 Abbott Lab Homotaurine process
US3658966A (en) 1969-09-15 1972-04-25 Kowa Co Methods of treating hypertension
US3920833A (en) 1974-08-08 1975-11-18 Stanley Drug Products Inc Antifibrinolytic agents
FR2437834A1 (fr) 1978-10-04 1980-04-30 Lejeune Jerome Compositions pharmaceutiques a base de l-serine ou de glycine
FR2457281A1 (fr) 1979-05-23 1980-12-19 Meram Lab Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee
US4255448A (en) 1979-09-10 1981-03-10 Wisconsin Alumni Research Foundation Method for reducing epileptiform activity
US4448779A (en) 1981-07-16 1984-05-15 Sanofi Use of MS salt in geriatric medicine
JPS5879022A (ja) 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
US4657704A (en) 1982-09-08 1987-04-14 Mitsui Toatsu Chemicals, Incorporated Production of aminoalkylsulfonic acids
US4737353A (en) 1984-04-13 1988-04-12 Union Carbide Corporation Beryllium-aluminum-phosphorus-silicon-oxide molecular sieve compositions
IT1173990B (it) 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
JPH0733332B2 (ja) 1985-11-19 1995-04-12 富山化学工業株式会社 痴呆症状改善・治療剤
JPH0786122B2 (ja) 1986-05-30 1995-09-20 日本ペイント株式会社 三次元架橋された微小樹脂粒子およびその製造法
US4847082A (en) 1987-01-21 1989-07-11 Robert Sabin Method of treatment of Alzheimer's disease using phytic acid
IT1205042B (it) 1987-05-28 1989-03-10 Crinos Industria Farmaco Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
IT1211792B (it) 1987-09-21 1989-11-03 Sigma Tau Ind Farmaceuti O-alcanoil derivati dell'acido 3ammino-2-idrossipropansolfonico adattivita'anticonvulsivante e loro composizioni farmaceutiche per il trattamento terapeutico dell'epilessia
JPH01171638A (ja) 1987-12-25 1989-07-06 Kanegafuchi Chem Ind Co Ltd 血清アミロイドａ蛋白用吸着体
JP2587842B2 (ja) 1987-12-09 1997-03-05 株式会社ニチレイ 神経疾患治療・予防剤
IT1212000B (it) 1987-12-24 1989-11-08 Sigma Tau Ind Farmaceuti Fenilbenziliden-derivati dell'acido 3)amminopropansolfonico ad attivita' anticonvulsivante e loro composizioni farmaceutiche per il trattamento terapeutico della epilessia
US4968678A (en) 1988-02-19 1990-11-06 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists
DE68905845T2 (de) 1988-02-19 1993-08-05 Lilly Co Eli Tetrazolverbindungen als antagonisten der excitatorischen aminosaeurerezeptoren.
JPH0627072B2 (ja) 1988-09-13 1994-04-13 呉羽化学工業株式会社 アミノ安息香酸誘導体を有効成分とする生体内抗酸化機構調節剤
JPH0667472B2 (ja) 1988-11-28 1994-08-31 鐘淵化学工業株式会社 血清アミロイドｐ蛋白用吸着体
US5061721A (en) 1989-03-15 1991-10-29 G. D. Searle & Co. Composition containing d-cycloserine and d-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder
JP2761048B2 (ja) 1989-08-25 1998-06-04 三共株式会社 神経成長因子産生促進剤
DE4004978A1 (de) 1990-02-19 1991-08-22 Nmi Naturwissenschaftl U Mediz Praeventive therapie fuer morbus alzheimer
JP2780846B2 (ja) 1990-05-01 1998-07-30 インペリアル・ケミカル・インダストリーズ・ピーエルシー 除草剤組成物
US5385915A (en) 1990-05-16 1995-01-31 The Rockefeller University Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation
US5242932A (en) 1991-12-17 1993-09-07 The Rockefeller University Treatment of amyloidosis associated with alzheimer disease
JPH0725786A (ja) 1990-05-16 1995-01-27 Univ Rockefeller アルツハイマー病を伴うアミロイドーシスの治療
DE4021066A1 (de) 1990-07-03 1992-01-09 Hoechst Ag Langzeitprophylaxe gegen erkrankungen, die durch viren oder durch unkonventionelle viren verursacht werden
EP0467856B1 (en) 1990-07-19 1997-03-19 Nippon Zoki Pharmaceutical Co. Ltd. Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases
JP2980749B2 (ja) 1990-11-30 1999-11-22 協和醗酵工業株式会社 フラン誘導体
US6746678B1 (en) 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
US5668117A (en) 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
US5164295A (en) 1991-03-06 1992-11-17 The Upjohn Company Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US5192753A (en) 1991-04-23 1993-03-09 Mcgeer Patrick L Anti-rheumatoid arthritic drugs in the treatment of dementia
GB9117716D0 (en) 1991-08-16 1991-10-02 Lynxvale Ltd Gaba derivatives and their therapeutic application
DK0548024T3 (da) 1991-12-19 1997-01-27 Ciba Geigy Ag Aminosulfonsyrederivater samt fremgangsmåder til deres fremstilling
US5318958A (en) 1992-05-29 1994-06-07 Queen's University At Kingston Amyloid precursor protein
US5276059A (en) 1992-07-10 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of diseases associated with amyloid formation
US5837672A (en) 1992-07-10 1998-11-17 Athena Neurosciences, Inc. Methods and compositions for the detection of soluble β-amyloid peptide
US5972328A (en) * 1993-03-29 1999-10-26 Queen's University At Kingston Method for treating amyloidosis
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US5643562A (en) * 1993-03-29 1997-07-01 Queen's University Of Kingston Method for treating amyloidosis
EP1060750B1 (en) * 1993-03-29 2005-12-07 Queen's University At Kingston Propane-1,3-disulfonic acid and its pharmaceutically acceptable salts for treating amyloidosis
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
AU7376494A (en) 1993-08-04 1995-02-28 Andrulis Pharmaceuticals Corporation Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents
US5488145A (en) 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
US5858326A (en) 1995-06-06 1999-01-12 Neurochem, Inc. Methods of increasing amyloid deposition
AU703540B2 (en) 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
US5989592A (en) 1996-10-03 1999-11-23 Coastside Bio Resources Inhibition of complement pathway by sea cucumber fractions
US6306909B1 (en) 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents
US5869469A (en) 1997-08-18 1999-02-09 Queen's University At Kingston Phosphonocarboxylate compounds for treating amyloidosis
US6294583B1 (en) 1998-01-13 2001-09-25 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
US20020022657A1 (en) 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
EP1054664B1 (en) * 1998-02-11 2012-08-08 BHI Limited Partnership Method for modulating macrophage activation
US6329356B1 (en) 1998-04-10 2001-12-11 Neurochem, Inc. Phosphono-carboxylate compounds for treating amyloidosis
US20030147882A1 (en) * 1998-05-21 2003-08-07 Alan Solomon Methods for amyloid removal using anti-amyloid antibodies
US6310073B1 (en) * 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
AU1143200A (en) * 1998-11-10 2000-05-29 Neurochem, Inc. Polymorphic forms of an amyloidosis inhibitor and methods of preparation
AU4282400A (en) 1999-04-28 2000-11-10 Neurochem (International) Limited Compositions and methods for treating amyloidosis
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
WO2001003680A2 (en) 1999-07-09 2001-01-18 Isis Innovation Limited Compounds for inhibiting diseases and preparing cells for transplantation
WO2001085093A2 (en) * 1999-12-23 2001-11-15 Neurochem, Inc. Compounds and methods for modulating cerebral amyloid angiopathy
US6376557B1 (en) 2000-03-16 2002-04-23 Chanda Bhuwalka Zaveri Methods for treating alopecia
US7311893B2 (en) 2000-07-25 2007-12-25 Neurochem (International) Limited Amyloid targeting imaging agents and uses thereof
US20020115717A1 (en) 2000-07-25 2002-08-22 Francine Gervais Amyloid targeting imaging agents and uses thereof
US20020151506A1 (en) * 2000-12-29 2002-10-17 Castillo Gerardo M. Catechins for the treatment of fibrillogenesis in Alzheimer's disease, Parkinson's disease, systemic AA amyloidosis, and other amyloid disorders
CA2434169C (en) * 2001-01-12 2011-03-15 Sun Pharmaceutical Industries Limited Spaced drug delivery system
EP1386166A2 (en) 2001-03-13 2004-02-04 Queen's University At Kingston Anti-epileptogenic agents
US7501429B2 (en) 2001-04-11 2009-03-10 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
EP1397136A1 (en) 2001-05-25 2004-03-17 Queen's University At Kingston Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents
US20040006092A1 (en) 2001-08-31 2004-01-08 Neurochem, Inc. Amidine derivatives for treating amyloidosis
CA2399169A1 (en) 2001-09-07 2003-03-07 Queen's University At Kingston Diagnostic methods for determining susceptibility to convulsive conditions
EP1585520A1 (en) * 2002-12-24 2005-10-19 Neurochem (International) Limited Therapeutic formulations for the treatment of beta-amyloid related diseases
US20050031651A1 (en) 2002-12-24 2005-02-10 Francine Gervais Therapeutic formulations for the treatment of beta-amyloid related diseases
WO2004113391A2 (en) * 2003-06-23 2004-12-29 Neurochem (International) Limited Improved pharmaceutical drug candidates and methods for preparation thereof
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20050215562A1 (en) 2003-06-23 2005-09-29 Patrick Tremblay Methods for treating protein aggregation disorders
US20050142191A1 (en) 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
US7253306B2 (en) * 2003-06-23 2007-08-07 Neurochem (International) Limited Pharmaceutical drug candidates and methods for preparation thereof
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20050038000A1 (en) 2003-06-23 2005-02-17 Xianqi Kong Methods and compositions for the treatment of amyloid-and epileptogenesis-associated diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7262223B2 (en) 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
US20080038192A1 (en) * 2004-07-19 2008-02-14 Neurochem Inc. Diagnostic Methods Of Multiple Organ Amyloidosis
AU2005310986A1 (en) 2004-11-12 2006-06-08 Bellus Health (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
WO2006059245A2 (en) 2004-11-16 2006-06-08 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis

Also Published As

Publication number Publication date
NO20075815L (no) 2008-01-11
EA018898B1 (ru) 2013-11-29
ES2534553T3 (es) 2015-04-24
CA2582556A1 (en) 2007-01-11
IL186544A0 (en) 2008-08-07
BRPI0610592A2 (pt) 2010-07-06
AU2006264498A1 (en) 2007-01-11
US8178580B2 (en) 2012-05-15
KR20130133915A (ko) 2013-12-09
DK1885350T3 (en) 2015-05-26
JP2013079260A (ja) 2013-05-02
HK1116686A1 (en) 2009-01-02
AU2006264498B2 (en) 2012-09-27
US20120270939A1 (en) 2012-10-25
IL186544A (en) 2014-02-27
RS54050B1 (en) 2015-10-30
EP1885350B1 (en) 2015-03-04
EP1885350B9 (en) 2015-06-17
EA200702237A1 (ru) 2008-06-30
TW200716088A (en) 2007-05-01
US20130296434A1 (en) 2013-11-07
MX2007012525A (es) 2007-12-06
HRP20150320T1 (en) 2015-07-03
CN101528216A (zh) 2009-09-09
IL230935A0 (en) 2014-03-31
HK1214158A1 (zh) 2016-07-22
ME02149B (me) 2015-10-20
CN104873483A (zh) 2015-09-02
CA2582556C (en) 2012-05-29
HUE026044T2 (en) 2016-05-30
EP2944308A1 (en) 2015-11-18
WO2007004072A3 (en) 2007-08-23
JP2008535906A (ja) 2008-09-04
JP5753152B2 (ja) 2015-07-22
PT1885350E (pt) 2015-04-29
US20060252829A1 (en) 2006-11-09
EP1885350A2 (en) 2008-02-13
WO2007004072B1 (en) 2007-12-27
PL1885350T3 (pl) 2015-08-31
WO2007004072A2 (en) 2007-01-11
ZA200709825B (en) 2009-04-29
KR20080003895A (ko) 2008-01-08
ES2534553T9 (es) 2015-06-25

Similar Documents

Publication Publication Date Title
HK1214158A1 (zh) 治療澱粉樣變性的製劑和方法
IL186973A0 (en) Compositions and methods for treatment for neoplasms
GB2423928B (en) Methods and compositions for treating pain
IL186963A0 (en) Methods and compositions for treating pain
IL185540A0 (en) Compositions and methods for treating acne
EP1890712A4 (en) COMPOSITIONS AND METHODS FOR TREATING PAIN
EP1959929A4 (en) COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING
EP1737482A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
EP1940437A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF BACTERIA
HK1123509A1 (en) Hair treatment compositions
HK1121952A1 (en) Methods and compositions for treating conditions
IL191072A0 (en) Therapeutic compositions and methods
IL186599A0 (en) Methods for treating and preventing fibrosis
EP1841397A4 (en) TRICHOLOGY FORMULATIONS AND TREATMENTS
EP1959931A4 (en) COMPOSITIONS AND METHODS FOR THE DERMAL TREATMENT OF PAIN
IL186408A0 (en) Combination treatment methods
IL176919A0 (en) Methods and compositions for treating cancer
ZA200803523B (en) Hair treatment compositions
ZA200608932B (en) Method and compositions for epilation
ZA200803524B (en) Hair treatment compositions
EP1971368A4 (en) COMPOSITIONS AND METHODS FOR TREATING THROMBOCYTOPENIA
EP1855662A4 (en) METHODS AND COMPOSITIONS FOR TREATING CANCER
ZA200608935B (en) Methods and compositions for epilation
GB0500451D0 (en) Hair treatment apparatus
EP1851190A4 (en) COMPOSITIONS AND METHODS FOR PAIN-RESISTANCE